- 1College of Food Engineering and Nutritional Science, Shaanxi Normal University, Xi’an, China
- 2National Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan
- 3Guilin Seamild Food Co., Ltd., Guilin, China
- 4School of Food and Biological Engineering, Chengdu University, Chengdu, China
Oats are considered the healthiest grain due to their high content of phytochemicals, dietary fibers, and protein. In recent years, oat protein and peptides have gained popularity as possible therapeutic or nutraceutical candidates. Generally, oat peptides with bioactive properties can be obtained by the enzymatic hydrolysis of proteins and are known to have a variety of regulatory functions. This review article focused on the nutraceutical worth of oat proteins and peptides and also describes the application of oat protein as a functional ingredient. Outcomes of this study indicated that oat protein and peptides present various therapeutical properties, including antidiabetic, antioxidant, antihypoxic, antihypertensive, antithrombotic, antifatigue, immunomodulatory, and hypocholestrolaemic. However, most of the conducted studies are limited to in vitro conditions and less data is available on assessing the effectiveness of the oat peptides in vivo. Future efforts should be directed at performing systematic animal studies; in addition, clinical trials also need to be conducted to fully support the development of functional food products, nutraceutical, and therapeutical applications.
Introduction
Oats are one of the most nutritious grains and are the 5th most consumed crop with an annual production of 23 million tons globally (1, 2). Generally, oat grains can be classified as naked oats (Avena nuda L.) and hulled oats (Avena stiva L.). Oats contain a relatively high content of protein, and it also comprises a considerable amount of lipids and other bioactive compounds, such as beta-glucans, phenolics (trace–150 mg/kg), avenanthramides (26–150 mg/kg), and flavonoids 1.77 mmol/g (3, 4). Depending on different varieties, oat grain comprises lipids 5–10%, crude protein 12–20%, crude fiber 3–14%, and carbohydrates 69–76% (5, 6). The protein content of oat grain is higher as compared to other cereals, including rice 7–10%, wheat 11–15%, and millets 7–11%, while lower than legumes, such as pea 23–31% and soy 36–40%. The protein fractions and their molecular weights are also significantly different among grains as given in Table 1 (6–10).
Globulin is the major storage protein in oats. Mainly, oat protein is composed of four fractions; globulin 70–80%, albumins 1–12%, prolamins 4–15%, and glutenins ≤ 10% (18). The salt soluble globulin fraction is divided into 3 subunits, 12S, 7S, and 3S. The molecular weight of globulin ranges from 54 to 60 kDa, which is approximate to the 11S globulin (glycinin) structure of soy protein (12, 13); besides this, 12S has acidic A and basic B polypeptides subunits with a molecular weight of 32 and 22 kDa, respectively (19). Other subunits of globulins, 7S has polypeptides of molecular weight of 55–65 kDa, and 3S contains two polypeptides of 15 and 21 kDa (17, 18). Water-soluble albumin plays a role as an enzyme in the protein and defensive system of plants, and its molecular weight ranges from 19 to 21 kDa (20). Prolamin (avenins), the alcohol-soluble protein fraction with a molecular weight of 20–40 kDa, has structural similarities with Sulfur rich sub-units of wheat (α and γ gliadins), γ-secalins of rye, and B-hordeins of barley proteins fractions (12, 19). This protein fraction is limiting in proline and glutamine amino acids but has the same function as the storage protein fraction (gluten) of wheat (21). The minor fraction (Glutelins) comprises polypeptides having a molecular weight of 10–90 kDa (20).
Oat protein contains a comparatively higher amount of essential amino acids, especially (lysine, valine, isoleucine, threonine, histidine, and methionine) than other grains. Amino acids composition of oat protein significantly differs even among its fractions, globulins carry the highest amount of essential amino acids, such as lysine, valine, phenylalanine, and histidine, as well as non-essential amino acids, including arginine and glutamic, as compared to all three other fractions (20). In addition, oat amino acids composition meets the Food and Agriculture Organization’s recommended nutritional needs of an adult except for methionine, which is still the limiting amino acid in oat protein (22). Furthermore, the consumer’s acceptability score of oat protein is also higher than any other plant-based pea, lupin, and soy proteins (20, 23, 24).
Plant protein has received much attention in recent years, as consumers are pursuing more plant-based diets in hopes of improving health and preserving the environment. Livestock puts much higher pressure on global warming, resource, and land use than plant-based food (25). Animal-based foods, including dairy, eggs, meat, and aquaculture, use 83% of the world’s cultivated land and contribute up to 58% of food emissions, while providing only 37% of the total proteins (26). The higher environmental impact of animal products is due to the high feed consumption per kilogram of food produced, in addition, a large part of greenhouse gas emissions comes from intestinal fermentation and fecal management in ruminants (26, 27). There is a need to reduce greenhouse gas emissions by minimizing the animal-based proteins, and substituting even only a part of animal protein intake with plant-based proteins would benefit both human health and the environment (28). Numerous studies have shown that plant products have less impact on climate and eutrophication and lower land use as compared to animal-based products. For example, beans and peas have the lowest land use per kg of protein as compared to milk, eggs, and poultry (29–31). Specifically, the carbon footprint of oat protein concentrate (OPC) is more than 50% lower when compared with dairy proteins (32). OPC-enriched food products could reduce 13% of greenhouse gas emissions and 26% of land use when substituted with animal-based proteins (33); similarly, oat drinks emitted 16–41% lesser greenhouse gas as compared to cow milk (34). The use of plant proteins has considerable potential in mitigating climate change and reducing land use. From this perspective, the above-mentioned studies reveal the potential that the oat protein made it possible to substitute some animal proteins with plant proteins.
Being of high protein content, sustainability, as well as good nutritional profile, oats are considered the promising cereals for extracting plant-based proteins and isolating bioactive peptides (35). Plant bioactive peptides, in general, are small fragments of proteins, composed of 2–20 amino acids and having less than 3 kDa molecular weight (36, 37). These peptides naturally exist or are derived from precursor proteins through gestational simulation, microbial fermentation, or enzymatic hydrolysis (38). It has been found that bioactive peptides have a simpler structure, higher stability, and more remarkable physiological activities and functions compared to protein (39). In this way, oat protein-derived bioactive peptides have been identified to exert distinct health improving properties, such as antidiabetic, immunomodulatory, antifatigue, antithrombosis, antihypoxic, antihypertensive, hypocholestrolaemic, and antioxidant effects (Figure 1). In this article, we mainly focus on the oat proteins in detail for their application as a functional ingredient and potential nutraceutical activities (Table 2).
Application of Oat Protein as a Functional Ingredient
Interest in protein-rich diets is increasingly favored by their health-promoting effects, with a special focus on sources. Plant-based protein is replacing animal protein as it is considered better for human consumption, as well as safe for the planet (40). The market request for developing plant protein-based products is continuously increasing because of high concern toward health, animal welfare, and environmental protection. This searching desire for alternative non-animal protein sources opens the way to the valorization of non-fully exploited plants and industrial by-products (33). With the increase in demand for nutrition products, oat protein-infused beverages, bakery items, supplements, and others are making their way into the market, as it contains high-quality protein and is also suitable for flavoring. Numerous studies have been conducted to review the possibility of using oat for the development of nutraceuticals. The lipid-lowering and antioxidant properties of oat protein make it a potential ingredient for nutraceuticals (41). Oat protein (OP) gels have been used for the preparation of prebiotic loaded nutraceuticals which can prevent the deterioration of prebiotics in gastric conditions. OP gels have been shown to resist pepsin digestion and have the capacity to release bioactive compounds during gastrointestinal simulation conditions (19). Due to growing interest in plant protein ingredients, oat has gained much attention for its unique amino acid composition, protein quality, and protein content. The global oat protein market reached US$ 48 million in 2018 and is expected to grow up to US$ 63 million by the end of 2025 with a compound annual growth rate of 4.1% during 2019–2025 (42). Regarding usage and composition, oat protein increased from 884t in 2012 to 1398 t in 2017 globally, with a compound annual growth rate of more than 9.6% (43).
In terms of using oat protein in food applications, oat protein has better sensory properties than legume and oilseed proteins (44). Oat protein concentrates and isolates can be easily incorporated into pasta and bakery products to improve their protein content. Although well suited to bakery products, the applicability of oat protein is still limited in semisolid and liquid foods because of its low solubility in natural and mildly acidic conditions (45). Oat protein is also a good replacer of skim milk powder because of its ability to produce better quality yogurt in terms of mouthfeel and syneresis. OPC due to the excellent techno-functional properties of the contained oat starch is an appropriate ingredient for the implementation of the nutritional value of oat protein, giving a healthier and more natural shape to the yogurt (46). Given the increased demand for a plant protein source, meat analogs produced from plant proteins have gained traction (47). The meat analogs’ market has long been dominated by pea, wheat gluten, and soy proteins (28). However, due to the presence of common allergens in pea and soy protein, the oat protein has the potential to play a significant role in the meat alternative market as a new protein ingredient (48). Besides, using oat protein in meat alternative analog or yogurt, oat milk is also included in the list of common oat products that dominate the market. The oat milk is a promising substitute for dairy products because it can be used in combination with probiotics to prepare fermented products like yogurt. Due to consumer awareness about plant-based milk and increased interest in flexitarian, vegan, and vegetarian diets, the international oat milk market reached US$ 4 billion in 2020 and is expected to grow with a compound annual growth rate of 9.8% by 2027 (49).
The presence of many substitutes like soya, whey, and others, which contain protein in heavy quantities and are demanded by the nutraceutical companies, lead to increased competition for oat protein products. In terms of food application, few oat protein products are available in the market given in Table 3, which urges food developers to build tailored strategies and food portfolios of these ingredients. As a functional food ingredient, oat protein application is still in the early stages, and food companies are investing in the production of high-quality oat protein products (44).
Nutraceutical Properties of Oat Protein-Derived Peptides
Antioxidant Activity
Oats are known to contribute to a significant supply of antioxidants in the form of phytic acid, phenolic compounds, vitamin E, and avnanthramides to counter oxidative stress (50). The antioxidant defense system works to balance the reactive oxygen species by superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), vitamins, minerals, and co-factors to prevent cellular oxidative stress. These antioxidant compounds demonstrated radical scavenging activities by participating in a single electron transfer reaction (51). Oat proteins have also been considered a good source of antioxidant capacity, which have the potential to strengthen the treatment of oxidation-linked disorders, delay the oxidation process in foods and improve quality of life (52). Oat protein isolates and hydrolysates exhibited excellent antioxidant activities when assessed for 2,2 Azino-Bis-Ethylbenzoline-6-Sulfonic acid (ABTS), (HO.), (O.2), and Fe(2+) chelating assays (53). Bioactive peptides (IRIPIL, FLKPMT, FNDILRRGQLL, LIGRPIIY, and NSKNFPTL) isolated from globulin fraction had the strongest 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) (IC50 = 4.11 ± 0.07 mg/mL) and hydroxyl (IC50 = 1.83 ± 0.03 mg/mL) radical scavenging activity (54). In another study, oat peptides (GLVYIL, YHNAP, and GQTV) showed cytoprotective and peroxyl radical scavenging potential with considerable oxygen radical absorbance capacity (ORAC) value 0.67 ± 0.02, 0.61 ± 0.04, and 0.52 ± 0.01 Trolox equivalent (TE)/μM, respectively. The cytoprotective activity of peptides GLVYIL, YHNAP, and GQTV was correlated with the overall hydrophobicity of peptides, but not with their ORAC values (55).
Oat hydrolysates exhibited a cytoprotective effect by protecting HepG2 cells from AAPH-induced oxidative stress by significantly magnifying the activities of antioxidant enzymes, including GPx, CAT, and SOD, and inhibiting reactive oxygen species (ROS) levels (56). Furthermore, lipid oxidation and linolenic acid peroxidation were significantly inhibited up to 52, 35, and 16% with NINAHSVVY, YFDEQNEQFR, and SPFWNINAH peptides, respectively (57). The presence of tyrosine on (N or C-terminal) and histidine in a sequence of peptides improved their activity, as both these amino acids have good electron or proton donating ability. Hydrophobicity is also an important factor to interact with lipids (57). A recent development to alleviate anemia and oxidative stress has been made by using oat antioxidant peptide as a carrier to synthesize a novel oat peptide-ferrous (OP-Fe+2) chelate. OP-Fe+2 has shown to be helpful to alleviate anemia and also improved the activities of antioxidant enzymes, including GSH and SOD, while limiting the malondialdehyde (MDA) content in the liver of iron-deficient anemic rats model (58). In addition, oat peptides effectively recovered the H2O2 induced apoptosis and oxidative stress in human dermal fibroblast by regulating cellular antioxidant enzymes (59). Collectively, these reports demonstrated that oat-derived peptides can reduce oxidative stress and related disorders and may contribute to the development of nutraceutical or functional foods.
Antidiabetic Activity
Oat peptides have the potential to inhibit dipeptidyl peptidase-4 (DPP4) and α-amylase and enhance the release of glucagon-like peptide-1 (GLP-1), as shown in Figure 2. Numerous dietary bioactive peptides work as antidiabetic agents by regulating insulin resistance and energy metabolism (60). Oat globulin peptides exhibited DPP4 inhibitory activity in vitro, with half-maximal inhibitory concentration (IC50) values of DPP4 at 100.4 μg/mL for peptide LQAFEPLR and 2.04 mg/mL for oat tryptic hydrolysates (61). Oat peptides showed improved DPP4 inhibition than fish peptides (42.5% at concentration of 5 mg/ml) and milk peptides IC50 = 0.60–2.14 mg/mL (55, 57, 62). Oat peptides inhibited the activity of DPP4 through binding to its active site with low binding energy and also downregulated the protein expression in Caco-2 cells. In addition, oat globulin peptides suppressed the α-glucosidase with IC50 of 35.67 μg/mL for LQAFEPLR and 113.8 μg/mL for hydrolysates (61). Walters et al. (63) have evaluated the antidiabetic potential of oat hydrolysates in NCI-H716 cells. The results indicate a significant inhibition of DPP4 (30.6–53.6%) and α-amylase (18–32%), and also improved insulin secretion, as well as glucose digestion. The inhibition mechanism has not been clarified, and a previous review (64) has shown that the inhibition of α-amylase by food-derived peptides usually occur through competitive binding between polysaccharide and peptides mainly through their aromatic amino acids. Another factor GLP-1 contributes to the stimulation of insulin, inhibition of glucagon by acting as an incretin hormone, and limits the postprandial glucose level. The secretion of glucagon-like peptide (GLP-1) was also improved in NCI-H716 cells, which ranges from 20.85 to 39.25 pM (picomole) (63). It has been shown that food-derived peptides affect gene expression, bile acid activation, and calcium receptors (65). Hence, peptidomics profile of hydrolysates is necessary to confirm their potential contribution to activity.
In another study, the peptides YFDEQNEQFR, NINAHSVVY, and RALPIDVL potentially inhibited α-amylase in vitro, with IC50 values of 37.5, 67.3, and 72.8 μM, respectively. The most active α-amylase inhibitory peptide was (YFDEQNEQFR) with acidic properties and containing tyrosine (Y) and arginine (R) amino acids, which may have contributed to the highest activity (57). Furthermore, oat peptides have been shown to effectively improve the symptoms of polydipsia, weight loss, and polyphagia, which can control the blood glucose level by improving insulin sensitivity and promoting glycogen synthesis (66). Oat grains and their bioactive compounds have been extensively studied for antidiabetic significance in human subjects. Regular oats intake for 23 weeks can improve fasting blood glucose level and insulin concentration by up to 20%, meanwhile, beta-glucans supplementation improves the blood glucose, insulin GLP-1, HbA1c, and appetite-regulating hormones in type 2 diabetic individuals (67, 68). However, work on the antidiabetic potential of oat peptides is still limited to in vitro studies; thus, systematic in vivo research is needed to fully understand the molecular mechanism behind the antidiabetic properties of oat bioactive peptides.
Antihypertensive Activity
Oat’s bioactive peptides have been shown to exert antihypertensive activity by targeting the renin–angiotensin system (RAS) (Figure 3). Oat protein isolates exhibited significant renin inhibitory activity, ranging from 40.50 to 70.5%, while the synthesized peptides showed comparatively lower inhibition than protein isolates. The attributes of renin inhibitory peptides are not clearly defined like ACE inhibitory peptides (69). Among the peptides, only IFFFL took part in renin inhibition due to the presence of bulky amino acids on the N-terminal, while the higher renin inhibitory activity of protein isolates could also be due to the presence of other bioactive compounds in protein, such as phenolic compounds (70). Oat protein isolates and peptides significantly inhibited the ACE, and protein isolates were found to inhibit ACE between 86.6 and 96.5%. The highest ACE inhibition value of protein is comparable with the positive control (captopril), which was found to inhibit the ACE by 97.7%. The synthesized peptides WCY, FLLA, and WWK were recorded for their highest ACE inhibition by 97.8, 97, and 95.3%, respectively. Peptide FEPL showed the lowest ACE inhibition value of 48.9% (70), and the lower ACE inhibition capacity of FEPL was due to the presence of proline, which has been suggested to reduce the binding affinity of the peptide with angiotensin-converting enzyme (ACE) (71).
Oat globulin peptide (SSYYPFK) was found to lower the systolic and diastolic blood pressure in a hypertensive rat model and exhibited high ACE inhibitory activity (IC50: 91.82μM). In addition, peptide SSYYPFK inhibited the renin by 28.6–45.59% and suppressed the production of intracellular endotheline-1 (ET-1) by 13.19–27.88% (72). Overexpression of ET-1 is an endogenous mediator of cardiovascular problems, such as hypertension or atherosclerosis. ET-1 and nitric oxide are important systems involved in the regulation of blood pressure, and peptide SSYYPFK may play an antihypertensive role by affecting these systems (73). Some clinical studies have been conducted on the antihypertensive effects of oatmeal, beta-glucan, dietary fibers, avenanthramides (AVA), and their fortified products. Most of these human interventional studies assessed the advantageous effects of oats and its derived active compounds in hypertensive and normotensive subjects by regulating systolic or diastolic blood pressure (74). Above mentioned research outcomes have confirmed that oat protein-derived peptides could effectively inhibit ACE and renin by targeting respective pathways and may be used as a functional ingredient for the prevention of hypertension and related disorders after interventional trials.
Immunomodulatory Effects
Oat bioactive peptides exhibited immunomodulatory activity by improving innate and adaptive immunity. Oat oligopeptides (OOPs) attributed to the significant enhancement in interleukin IL, serum interferon (IFN)- γ, tumor necrosis factor (TNF)-α, T and Th cells percentage, immunoglobulin IgA, IgG production, as well as granulocyte macrophages colony-stimulating factors (GM-CSF) secretions (75). It also found that after OOP’s treatment, the percentage of CD3+ and CD4+ were enhanced, indicating the improvement in T cells quantity, which results in cytokines secretions and mediated cellular immune response (75). Specifically, CD4-T cells consists of T helper-1 (Th1) cells, which induce a cell-mediated immune response by producing IL-2, TNF-α, INF- γ, T-helper 2 (Th2), and GM-CSF to induce humorous responses by secreting IL-4, IL-5, and IL-10 cytokines (76). A previous review has shown that oat gluten protein and peptides can significantly enhance the ability of ConA-induced splenic lymphocyte transformation and delayed-type allergy. Meanwhile, a combination of oat peptides with American ginseng peptides has been shown to significantly improved the mice’s immunity (77). Hence, oat bioactive peptides are a potential source to improve immunity; however, the exact mechanism through which food-derived bioactive peptides regulate the immune system remains unclear.
Antihypoxic Effects
Bioactive peptides from plant and animal sources have received much attention for their potential role in preventing hypoxia and other metabolic disorders (78–80). Oat oligopeptides (OOPs) can effectively ameliorate Hb, RBC, and Hct levels, which improves the oxygen-carrying capacity, as well as oxygen utilization rate of blood (81). The oxygen-carrying capacity of blood is directly reflected by the number of red blood cells and (HCT) indicating the volume ratio of RBCs to whole blood. Oxygen is attached to an iron atom and transported to the whole blood, and hemoglobin (Hb) combines with oxygen to transfer it from higher content areas to lower one’s, where it is needed (74, 77).
Oat oligopeptides also suppressed lactate and increased the activity of LDH, consequently upsurging the ability of the brain against lactic acidosis. The brain is more susceptible to oxidation because of its lipid membrane and weak antioxidant system. In the case of hypoxia, mitochondrial oxidase cannot completely reduce oxygen to water, resulting in the accumulation of reduced equivalent in the respiratory chain, which ultimately produces ROS. These factors trigger the lipid peroxidation in the brain and consequently, alkanes, epoxy fatty acids, alkanals, alkenals, and aldehyde, such as MDA, are produced (82–85). OOPs have been shown to decrease the MDA content of the brain, which minimizes lipid peroxidation and promotes angiogenesis, ultimately improving the hypoxic response (81).
Antifatigue Activity
Oat bioactive peptides can alleviate the exercise-induced fatigue by improving muscle strength (86). Lactic acid accumulation and acidosis are widely considered to cause an increase in hydrogen ion concentration, which leads to a decreased action potential, inhibited sarcoplasmic reticulum uptake, and the release of calcium ions (87). Oat peptides effectively upregulated lactate dehydrogenase and suppressed the production of lactic acid. In addition, oat peptides downregulated the blood urea nitrogen and increased the level of glycogen in the liver and muscles (86). In another study, oat protein isolates have shown to significantly improve the physiological condition of mice by increasing the level of liver glycogen up to (19.64%), enhancing the activities of superoxide dismutase SOD by 20.27% in blood and 81.32% in muscles, and lactic dehydrogenase LDH (13.58%), and decreasing the level of malondialdehyde MDA by 3.45% in blood and 53.12% in muscles, and blood urea nitrogen BUN by 18.25% (88). Normally, hepatic glycogen plays an important role to complement blood glucose consumption and maintain its level in the physiological range. In the case of intensive exercise, glycogen depletion severely limits energy supply and maximal power output. Consequently, fatigue may happen, when most of the glycogen is consumed from the liver (89, 90). Urea is formed as the end product of protein metabolism in the liver, and blood urea nitrogen (BUN) is another sensitive parameter of fatigue, which dramatically increases after intensive exercise (91–93). Furthermore, decreased level of lactate dehydrogenase (LDH) is a biomarker of muscle damage. It is an enzyme of the glycolytic pathway and is dependent on NAD+ for the interconversion of pyruvate and lactate (94).
A clinical study confirmed that the supplementation of oat protein for 14 days prior and 4 post-exercise days alleviated the exercise-induced fatigue by preventing physical discomfort and reducing the elevation of plasma biomarkers, including creatine kinase, IL-6, C-reactive protein, and myoglobin content. In addition, oat protein prevented the decline of joint range of motion, jump performance, and muscle strength, and enhanced the post-exercise recovery of damaged muscles in healthy adults (95). These scientific studies depicted that oat protein can effectively alleviate exercise-induced fatigue.
Antithrombotic Activity
The arachidonic acid (AA) pathway plays an important role in the platelet’s aggregation, AA directly acts on the COX1–TXA2 synthase pathway to produce TXA2. COX1 is a key enzyme in this pathway, associated with the metabolism of AA to induce TXA2 formation (96, 97). Finally, TXA2 causes changes in the shape of the platelet and activates fibrinogen receptors, consequently leading to platelet aggregation (98, 99). Hydrolysates produced from oats, barley, and buckwheat have been reported to have a crucial role in inhibiting platelet aggregation. Among all, oat hydrolysates showed high antiplatelet activity with an IC50 value of 0.282 mg/mL (100). Furthermore, oat globulin (small, mid, and large sized) fractions significantly inhibited the AA-induced platelet aggregation by (67.69, 17.98, and 14.33%) and increased the inhibitory rate to 73.11, 75.37, and 69.23%, respectively. These values are very close to the inhibitory rate of ASA (88.3%), which is a medical standard. The small-sized oat fraction showed more activity as compared to mid and large-size fractions (100). These results show that the inhibition of platelet aggregation by oat-derived bioactive peptides/hydrolysates could affectively act on COX1-TXA2 synthase pathway and may be employed to manage thrombosis and related chronic disorders.
Hypocholesterolemic Effects
The cholesterol-lowering activity of oats is often attributed to its ability to reduce cholesterol absorption in the intestine or inhibit the enterohepatic circulation of bile acids by increasing the carriage of cholesterol and bile acid in the colon to facilitate their excretions through the feces. Oat contains numerous bioactive compounds to regulate cholesterol metabolism in animals (101). Hypocholestrolaemic activity of oat is strongly dependent upon their protein composition. A related study depicted a significant reduction in liver and plasma cholesterol levels of rats fed with hypercholestrolaemic diet by increasing fecal bile acids secretions (102). Oat protein significantly reduced the plasma low-density lipoprotein (LDL-C) and total cholesterol level in the liver by increasing the excretion of bile acids and regulating the liver CYP7A1 activity in an animal model (103). Regulation of specific genes and enzymes, such as LDLR, HMG CoA reductase, HYP3A4, and CYP7A1, is mainly involved in cholesterol homeostasis by converting cholesterol to bile acids or transporting it to hepatic cells and in bile acids metabolism (104).
A clinical study exhibited a significant reduction in triglycerides and total cholesterol of 268 hypercholesterolemic adults after consuming whole oat gain and β-glucan fortified products (105). Oat bran containing β-glucan was recorded for its remarkable effects in hyperchlesterolemic individuals and lowered the cholesterol by 23% without affecting the level of high-density lipoprotein HDL in the blood (106). Similarly, another clinical study claimed that the consumption of 6 g oat β-glucan for eight consecutive weeks effectively reduced the plasma LDL and total cholesterol (from 167.9 to 120.9 mg/dL and 231.8 to 194.2 mg/dL, respectively) and increased the plasma HDL from 39.4 to 49.5 mg/dL in overweight individuals with mild hypercholesterolemia (107). However, limited studies have been found on the hypocholestrolemic effects of oat protein and peptides.
Processing and Purification of Bioactive Peptides
Processing of Bioactive Peptides
Bioactive peptides are defined as specific fragments of proteins that have positive effects on body functions and improve human health. The composition and sequence of amino acids determine the activity of peptides when they are released from a precursor protein, where they are encrypted (108). Generally, bioactive peptides are produced by microbial fermentation or by the enzymatic hydrolysis of protein. Several microorganisms, including Streptococcus salivarius ssp. thermophilus, Lactobacillus helveticus, Lactococcus lactis ssp. diacetylactis, Lactobacillus delbrueckii ssp. Bulgaricus, and Lactococcus lactis ssp. cremoris, have been reported for their effective action to produce bioactive peptides or hydrolysates from natural food sources (109). In addition to live microbes, lactic acid-bacteria-derived proteolytic enzymes have also been successfully used for protein hydrolysis to produce bioactive peptides. Although microbial fermentation is mainly relevant to the production of peptides from dairy products, it has been shown that fermentation can also produce bioactive peptides from beans, wheat, rice, and soy (110–113).
Enzymatic hydrolysis is a more efficient, safe, and reliable method than microbial fermentation as it takes less reaction time and is easy to control; additionally, it can be used to improve the biological and functional properties of proteins (114). These enzymes catalyze the hydrolysis of peptides bonds and may act on ester or amide bonds. All proteases have a certain degree of specificity in their substrate, generally based on a sequence of amino acids directly surrounding the bond that is cleaved (115). An extensive variety of bioactive hydrolysates and peptides have been produced from peanut, corn, soy, whey, and other protein sources (116–119). A conventional approach is mostly used to produce and identify the bioactive peptides (Figure 4). The efficacy of hydrolysates or peptides strongly depends upon the protein source, pretreatment of protein, proteases, and other hydrolysis factors, such as time, pH, and temperature (120). Proteases mainly involve two groups of enzymes i.e., exopeptidase (acts on amino or carboxyl ends of protein or peptides) and endopeptidase (acts on the interior of protein sequence) to break the peptide bonds (121). Most of the commercially available enzymes used for the production of bioactive peptides are derived from animals (e.g., pepsin or trypsin), microbial (e.g., Alcalase, Flavourzyme, and Neutrase), and plants (bromelain and papain) origin (122). Apart from commercial enzymes, some studies reported the crude enzymes for protein hydrolysis, suggesting the potential application of novel proteases source to produce bioactive peptides.
Several physical techniques, such as ultrasound, microwave, and high pressure, have been reported to show favorable effects on increased hydrolysis and release of potent bioactive peptides from precursor protein (123). Utilizing these cell disruptive green extraction techniques has proved to be more effective in protein recovery with minimum environmental pollution and also improves the yield, functional, and nutritional properties of proteins (124). The Ultrasonic waves can disrupt the food matrix and facilitate the extraction of protein (125). Ultrasound treatment can also affect the secondary structure of proteins, which can alter their behavior during enzymatic hydrolysis and consequently, improve the biological activities of hydrolysates. Numerous studies have shown the favorable effects of ultrasound on protein isolates of oat, corn, sunflower, rapeseed, and whey protein, as it helped in producing more active hydrolysates and short peptides, as well as improved the physicochemical and functional properties of protein isolates (63, 126–129). The microwave was shown to aid in chia seed proteolysis with improved bioactivity (antioxidant activity) and functionality (foaming and emulsifying properties) in a shorter time than simple enzymatic hydrolysis (130). Similarly, a pulsed electric field can enhance the antioxidant capacity of pine nuts by changing the secondary and tertiary structure of pentapeptide and protein (131). In addition to the above-mentioned isolation methods, chemical synthesis has also been used to obtain antioxidant, DPP4, and ACE inhibitory bioactive peptides (47, 64, 62). Most of the oat protein-derived bioactive peptides and hydrolysates discussed in this review have been produced using microbial and plant-based enzymes, including Alcalase, flavourzyme, and papain, while some peptides are produced by using gastrointestinal enzymes (trypsin and pepsin) as they mimic normal human digestion (48, 56, 94). However, enzyme–substrate ratio, degree of hydrolysis, and hydrolysis time are the important factors that need to be considered during the enzymatic hydrolysis process.
Purification and Identification of Bioactive Peptides
Enzymatic hydrolysates need appropriate separation and purification to evaluate the structure–activity relationship as it contains a mixture of several bioactive peptides, unhydrolyzed protein, and polypeptides of different lengths among others. To evaluate the accurate structure–activity relationship, various separation and purification techniques, including membrane separation, size-exclusion chromatography, HPLC, UPLC, and RP-HPLC, are widely used to get purified bioactive peptides (132). Ultra-high pressure chromatography (UPLC) is most suitable to purify the small-sized bioactive peptides. The main advantages of UPLC include increased resolution, throughput, and sensitivity (133). Reverse-phase chromatography (RP-HPLC) is used to separate the peptides based on hydrophobicity (134). The hydrophilic interaction liquid chromatography (HILIC) is a useful technique to separate the hydrophilic peptides (135). In addition, HILIC is a valuable tool to improve the separation of short peptides and the differentiation of homologous sequence peptides through mass spectrometry (136). Membrane separations or ultrafiltration and gel electrophoresis have also been used as subsidiary approaches for the chemical or structural configuration of peptides (132, 137). Similarly, electrodialysis with filtration membrane (EDFM) could fractionate the active peptides from complex hydrolysates on a molecular charge and mass basis (138, 139). After a series of isolation and purification procedures, the peptide’s structure, and composition need to be identified. It is worth noting that mass spectrometry has greatly improved the process of studying protein profiles or hydrolysis products and identifying peptides’ sequence. Liquid chromatography mass-spectrometry (LC-MS) is most commonly used in the identification of peptides sequence due to the advantages of high efficacy, sensitivity, and good reproducibility (140, 141).
Peptides with antioxidant activity that were obtained from oat globulin by using alcalase were initially separated and purified with chromatography, and the most active fraction was applied to ESI-MS/MS to identify the sequence as FNDILRRGQLL, IRIPL, FLKPNIT, NSKNFPTL, and LIGRPIIY (54). Similarly, antidiabetic peptides that were also obtained from the hydrolysis of oat globulin with trypsin were passed through an ultrafiltration membrane and further purified on gel chromatography, and the peptides elute was applied to Nano-LC-ESI-MS/MS for sequence identification. Two highly active antidiabetic peptides were identified as LQAFEPLR and EFLLAGNNK (61). Although ultra-filtration can significantly increase the bioactivity of peptides, this technique is not enough to get a highly pure product. Besides, the membrane is easily blocked by raw material, which causes pollution and the waste of raw material. Different techniques have some advantages and disadvantages, which make it difficult to obtain ideal peptides by using only a single technology. Therefore, the combination of separation techniques can attain precise classification and separation of peptides mixture to obtain high pure peptides.
Conclusion and Recommendation
In summary, oats protein with higher content, unique amino acid composition, and less environmental impact in sense of land use, GHG emissions, and carbon footprint is a potential candidate for developing plant protein-based functional products. Oat protein with no allergic characteristics is likely to play a significant role in the meat alternative market over pea and soy proteins. It can be used to incorporate as a functional ingredient in various food products or to produce improved quality yogurt. Besides, the health benefits of oat protein and peptides make these compounds nutraceutical food additives in the formulation of functional foods. Enzymatic hydrolysis is a more efficient and reliable method to produce active peptides. Oat peptides have been shown to have remarkable biological activities by targeting specific molecular pathways of various chronic disorders. These peptides are considered health improving and disease-preventing agents by functioning as an antidiabetic, antihypertensive, antioxidant, anti-hypoxia, anti-fatigue, antithrombotic, and anti-hypercholesterolemia among others. However, more research should be carried out to evaluate the bioavailability and interactions of oat peptides with other food components and body organs to determine their wellbeing for human consumption. It is also important to develop and implement strategies to confirm the valorization of the nutritional and functional potential of oat protein and peptides for their exploration in the development of marketable nutraceutical and functional foods.
Author Contributions
HR collected the data and drafted the manuscript. RD and XW helped to design the study. AA constructed the figures. RA, LZ, and LL revised the manuscript. XH supervised, revised, and approved the final version for publication. All authors contributed to the article and approved the submitted version.
Funding
This work was funded by the China Agriculture Research System of MOF and MARA (CARS-07-E), Shaanxi International Science and Technology Cooperation Bases (2019GHJD-15), and Cereal Food Science and Nutrition Innovation Team (2020TD-049).
Conflict of Interest
LL was employed by Guilin Seamild Food Co., Ltd.
The remaining authors declare that the research was conducted in the absence of a commercial or financial relationship that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We acknowledge all the researchers who have contributed to an extensive work toward oat protein, bioactive peptides, and their dietary and nutraceutical or health-protecting benefits.
References
1. Guerrieri N, Cavaletto M. Cereals proteins. In: Yada RY editor. Proteins in Food Processing. (Kidlington: Elsevier) (2018). p. 223–44. doi: 10.1111/j.1365-2621.1946.tb16361.x
2. FAO, Brief D. World Food Situation. Rome: Food and Agriculture Organization of the United Nations (2019).
3. Cui YF. Oats Nutrition and Technology. Illinois, United States: John Wiley & Sons (2014). p. 171–94.
4. Menon R, Gonzalez T, Ferruzzi M, Jackson E, Winderl D, Watson J. Oats—from farm to fork. Adv Food Nutr Res. (2016) 77:1–55. doi: 10.1016/bs.afnr.2015.12.001
5. Biel W, Jacyno E, Kawȩcka M. Chemical composition of hulled, dehulled and naked oat grains. S Afr J Anim Sci. (2014) 44:189–97.
6. Beloshapka AN, Buff PR, Fahey GC, Swanson KS. Compositional analysis of whole grains, processed grains, grain co-products, and other carbohydrate sources with applicability to pet animal nutrition. Foods. (2016) 5:23. doi: 10.3390/foods5020023
7. Boukid F, Zannini E, Carini E, Vittadini E. Pulses for bread fortification: a necessity or a choice? Trends Food Sci Technol. (2019) 88:416–28.
8. Wijewardana C, Reddy KR, Bellaloui N. Soybean seed physiology, quality, and chemical composition under soil moisture stress. Food Chem. (2019) 278:92–100. doi: 10.1016/j.foodchem.2018.11.035
9. de Oliveira Silva F, Miranda TG, Justo T, da Silva Frasão B, Conte-Junior CA, Monteiro M. Soybean meal and fermented soybean meal as functional ingredients for the production of low-carb, high-protein, high-fiber and high isoflavones biscuits. LWT. (2018) 90:224–31.
10. Majid A, Priyadarshini CGP. Millet derived bioactive peptides: a review on their functional properties and health benefits. Crit Rev Food Sci Nutr. (2020) 60:3342–51. doi: 10.1080/10408398.2019.1686342
11. Žilić S, Barać M, Pešić M, Dodig D, Ignjatović-Micić D. Characterization of proteins from grain of different bread and durum wheat genotypes. Int J Mol Sci. (2011) 12:5878–94. doi: 10.3390/ijms12095878
12. Nivala O, Mäkinen OE, Kruus K, Nordlund E, Ercili-Cura D. Structuring colloidal oat and FABA bean protein particles via enzymatic modification. Food Chem. (2017) 231:87–95. doi: 10.1016/j.foodchem.2017.03.114
13. Zhang B, Guo X, Zhu K, Peng W, Zhou H. Improvement of emulsifying properties of oat protein isolate–dextran conjugates by glycation. Carbohydr Polym. (2015) 127:168–75. doi: 10.1016/j.carbpol.2015.03.072
14. Amagliani L, O’Regan J, Kelly AL, O’Mahony JA. Composition and protein profile analysis of rice protein ingredients. J Food Compos Anal. (2017) 59:18–26.
15. Monteiro PV, Sudharshana L, Ramachandra G. Japanese barnyard millet (Echinochloa frumentacea): protein content, quality and SDS–PAGE of protein fractions. J Sci Food Agric. (1988) 43:17–25.
16. Adebiyi AP, Aluko RE. Functional properties of protein fractions obtained from commercial yellow field pea (Pisum sativum L.) seed protein isolate. Food Chem. (2011) 128:902–8.
17. Graveland A, Bosveld P, Lichtendonk WJ, Moonen HEH, Scheepstra A. Extraction and fractionation of wheat flour proteins. J Sci Food Agric. (1982) 33:1117–28.
18. Nieto-Nieto TV, Wang YX, Ozimek L, Chen L. Inulin at low concentrations significantly improves the gelling properties of oat protein – a molecular mechanism study. Food Hydrocoll. (2015) 50:116–27.
19. Yang C, Wang Y, Chen L. Fabrication, characterization and controlled release properties of oat protein gels with percolating structure induced by cold gelation. Food Hydrocoll. (2017) 62:21–34.
20. Jing X, Yang C, Zhang L. Characterization and analysis of protein structures in oat bran. J Food Sci. (2016) 81:C2337–43. doi: 10.1111/1750-3841.13445
21. Anderson OD. The spectrum of major seed storage genes and proteins in oats (Avena sativa). PLoS One. (2014) 9:e83569. doi: 10.1371/journal.pone.0083569
22. World Health Organization, United Nations University. Protein and Amino acid Requirements in Human Nutrition. Geneva: World Health Organization (2007). p. 1–265.
23. Walters ME, Udenigwe CC, Tsopmo A. Structural characterization and functional properties of proteins from oat milling fractions. J Am Oil Chem Soc. (2018) 95:991–1000.
24. Brückner-Gühmann M, Banovic M, Drusch S. Towards an increased plant protein intake: rheological properties, sensory perception and consumer acceptability of lactic acid fermented, oat-based gels. Food Hydrocoll. (2019) 96:201–8.
25. Van Zanten HHE, Herrero M, Van Hal O, Röös E, Muller A, Garnett T. Defining a land boundary for sustainable livestock consumption. Glob Chang Biol. (2018) 24:4185–94. doi: 10.1111/gcb.14321
26. Poore J, Nemecek T. Reducing food’s environmental impacts through producers and consumers. Science. (2018) 360:987–92.
27. Shepon A, Eshel G, Noor E, Milo R. Energy and protein feed-to-food conversion efficiencies in the US and potential food security gains from dietary changes. Environ Res Lett. (2016) 11:105002.
28. Heusala H, Sinkko T, Mogensen L, Knudsen MT. Carbon footprint and land use of food products containing oat protein concentrate. J Clean Prod. (2020) 276:122938.
29. Carlsson-Kanyama A, González AD. Potential contributions of food consumption patterns to climate change. Am J Clin Nutr. (2009) 89:1704–9. doi: 10.3945/ajcn.2009.26736AA
30. Xue X, Landis AE. Eutrophication potential of food consumption patterns. Environ Sci Technol. (2010) 44:6450–6. doi: 10.1021/es9034478
31. Nijdam D, Rood T, Westhoek H. The price of protein: review of land use and carbon footprints from life cycle assessments of animal food products and their substitutes. Food Policy. (2012) 37:760–70.
32. Heusala H, Sinkko T, Sözer N, Hytönen E, Mogensen L, Knudsen MT. Carbon footprint and land use of oat and faba bean protein concentrates using a life cycle assessment approach. J Clean Prod. (2020) 242:1–9.
33. Mogensen L, Heusale H, Sinkko T, Poutanen K, Sözer N, Hermansen JE. Potential to reduce GHG emissions and land use by substituting animal-based proteins by foods containing oat protein concentrate. J Clean Prod. (2020) 10:122914.
34. Röös E, Patel M, Spångberg J. Producing oat drink or cow’s milk on a Swedish farm – environmental impacts considering the service of grazing, the opportunity cost of land and the demand for beef and protein. Agric Syst. (2016) 142:23–32.
35. Gorissen SHM, Crombag JJR, Senden JMG, Waterval WAH, Bierau J, Verdijk LB. Protein content and amino acid composition of commercially available plant-based protein isolates. Amino Acids. (2018) 50:1685–95. doi: 10.1007/s00726-018-2640-5
36. Sarmadi BH, Ismail A. Antioxidative peptides from food proteins: a review. Peptides. (2010) 31:1949–56. doi: 10.1016/j.peptides.2010.06.020
37. Chalamaiah M, Ulug SK, Hong H, Wu J. Regulatory requirements of bioactive peptides (protein hydrolysates) from food proteins. J Funct Foods. (2019) 58:123–9.
38. Rabail R, Khan MR, Mehwish HM, Rajoka MSR, Lorenzo JM, Kieliszek M. An overview of chia seed (Salvia hispanica L.) bioactive peptides’ derivation and utilization as an emerging nutraceutical food. Front Biosci Landmark. (2021) 26:643–54. doi: 10.52586/4973
39. Jiang N, Zhang S, Zhu J, Shang J, Gao X. Hypoglycemic, hypolipidemic and antioxidant effects of peptides from red deer antlers in streptozotocin-induced diabetic mice. Tohoku J Exp Med. (2015) 236:71–9. doi: 10.1620/tjem.236.71
40. Boukid F. Plant-based meat analogues: from niche to mainstream. Eur Food Res Technol. (2021) 247:297–308.
41. Shah A, Masoodi FA, Gani A, Ashwar BA. Newly released oat varieties of himalayan region –techno-functional, rheological, and nutraceutical properties of flour. LWT. (2016) 70:111–8.
42. 360 Market Updates. Global Oat Protein Market Insighs, Forecast to 2025. Pune: 360 Market Updates (2018).
43. Mel R, Malalgoda M. Oat protein as a novel protein ingredient: structure, functionality, and functionality, and factors impacting utilization. Cereal Chem. (2022) 99:21–36.
44. Boukid F. Oat proteins as emerging ingredients for food formulation: where we stand? Eur Food Res Technol. (2021) 247:535–44.
45. Mäkinen OE, Sozer N, Ercili-Cura D, Poutanen K. Protein from oat: structure, processes, functionality, and nutrition. In: Nadathur SR, Wanasundra JPD, Scanlin L editors. Sustainable Protein Sources. (Cambridge, MA: Academic Press) (2017). p. 105–19.
46. Brückner-Gühmann M, Benthin A, Drusch S. Enrichment of yoghurt with oat protein fractions: structure formation, textural properties and sensory evaluation. Food Hydrocoll. (2019) 86:146–53.
47. Kyriakopoulou K, Dekkers B, van der Goot AJ. Plant-based meat analogues. In: CM Galanakis editor. Sustainable meat Production and Processing. (London: Academic Press) (2019). p. 103–26.
48. de Angelis D, Kaleda A, Pasqualone A, Vaikma H, Tamm M, Tammik ML. Physicochemical and sensorial evaluation of meat analogues produced from dry-fractionated pea and oat proteins. Foods. (2020) 9:1754. doi: 10.3390/foods9121754
49. Grand View Research. Oat milk Market size, Share and Trends Analysis Report by Product (Plain, Flavored), by Source (Organic, Conventional), by Application (Food, Beverages), by Region (Europe, APAC, North America), and Segment Forecasts, 2020-2027. Pune: Grand View Research (2020).
51. Chen J, Hu Y, Wang J, Hu H, Cui H. Combined effect of ozone treatment and modified atmosphere packaging on antioxidant defense system of fresh-cut green peppers. J Food Process Preserv. (2016) 40:1145–50.
52. Baakdah MM, Tsopmo A. Identification of peptides, metal binding and lipid peroxidation activities of HPLC fractions of hydrolyzed oat bran proteins. J Food Sci Technol. (2016) 53:3593–601. doi: 10.1007/s13197-016-2341-6
53. Esfandi R, Willmore WG, Tsopmo A. Peptidomic analysis of hydrolyzed oat bran proteins, and their in vitro antioxidant and metal chelating properties. Food Chem. (2019) 279:49–57.
54. Ma S, Zhang M, Bao X, Fu Y. Preparation of antioxidant peptides from oat globulin. CyTA J Food. (2020) 18:108–15.
55. Du Y, Esfandi R, Willmore WG, Tsopmo A. Antioxidant activity of oat proteins derived peptides in stressed hepatic HepG2 cells. Antioxidants. (2016) 5:39. doi: 10.3390/antiox5040039
56. Esfandi R, Willmore WG, Tsopmo A. Antioxidant and anti-apoptotic properties of oat bran protein hydrolysates in stressed hepatic cells. Foods. (2019) 8:160. doi: 10.3390/foods8050160
57. Esfandi R, Seidu I, Willmore W, Tsopmo A. Antioxidant, pancreatic lipase, and α−amylase inhibitory properties of oat bran hydrolyzed proteins and peptides. J Food Biochem. (2021) 46:e13762. doi: 10.1111/jfbc.13762
58. He YQ, Yang PY, Ding YY, Chen M, Guo R, Duan YQ. The preparation, antioxidant activity evaluation, and iron-deficient anemic improvement of oat (Avena sativa L.) peptides–ferrous chelate. Front Nutr. (2021) 8:687133. doi: 10.3389/fnut.2021.687133
59. Feng B, Ma L, Yao J, Fang Y, Mei Y, Wei S. Protective effect of oat bran extracts on human dermal fibroblast injury induced by hydrogen peroxide. J Zhejiang Univ Sci B. (2013) 14:97–105. doi: 10.1631/jzus.B1200159
60. Chakrabarti S, Jahandideh F, Davidge ST, Wu J. Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) enhance insulin sensitivity and prevent insulin resistance in 3T3-F442A preadipocytes. J Agric Food Chem. (2018) 66:10179–87. doi: 10.1021/acs.jafc.8b02051
61. Wang F, Zhang Y, Yu T, He J, Cui J, Wang J. Oat globulin peptides regulate antidiabetic drug targets and glucose transporters in Caco-2 cells. J Funct Foods. (2018) 42:12–20.
62. Wang TY, Hsieh CH, Hung CC, Jao CL, Chen MC, Hsu KC. Fish skin gelatin hydrolysates as dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 stimulators improve glycaemic control in diabetic rats: a comparison between warm-and cold-water fish. J Funct Foods. (2015) 19:330–40.
63. Walters ME, Willmore WG, Tsopmo A. Antioxidant, physicochemical, and cellular secretion of glucagon-like peptide-1 properties of oat bran protein hydrolysates. Antioxidants. (2020) 9:557. doi: 10.3390/antiox9060557
64. Payan F. Structural basis for the inhibition of mammalian and insect α-amylases by plant protein inhibitors. Biochim Biophys Acta. (2004) 1696:171–80. doi: 10.1016/j.bbapap.2003.10.012
65. Kim K, Park M, Lee YM, Rhyu MR, Kim HY. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation. Arch Pharm Res. (2014) 37:1193–200. doi: 10.1007/s12272-014-0362-0
66. Wang JB, Liu XR, Liu SQ, Mao RX, Hou C, Zhu N, et al. Hypoglycemic effects of oat oligopeptides in high-calorie diet/STZ-induced diabetic rats. Molecules. (2019) 24:558. doi: 10.3390/molecules24030558
67. Rytter E, Erlanson-Albertsson C, Lindahl L, Lundquist I, Viberg U, Åkesson B. Changes in plasma insulin, enterostatin, and lipoprotein levels during an energy-restricted dietary regimen including a new oat-based liquid food. Ann Nutr Metab. (1996) 40:212–20. doi: 10.1159/000177921
68. Pino JL, Mujica V, Arredondo M. Effect of dietary supplementation with oat β-glucan for 3 months in subjects with type 2 diabetes: a randomized, double-blind, controlled clinical trial. J Funct Foods. (2021) 77:104311.
69. Fisher NDL, Hollenberg NK. Renin inhibition: what are the therapeutic opportunities? J Am Soc Nephrol. (2005) 16:592–9.
70. Bleakley S, Hayes M, O’Shea N, Gallagher E, Lafarga T. Predicted release and analysis of novel ACE-I, renin, and DPP-IV inhibitory peptides from common oat (Avena sativa) protein hydrolysates using in silico analysis. Foods. (2017) 6:108. doi: 10.3390/foods6120108
71. Hong S, Cheung HS, Wang F, Ma O, Ef S. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme: importance of the COOH-terminal dipeptide sequence. J Biol Chem. (1980) 255:401–7.
72. Zheng Y, Wang X, Zhuang Y, Li Y, Shi P, Tian H. Isolation of novel ACE-inhibitory peptide from naked oat globulin hydrolysates in silico approach: molecular docking, in vivo antihypertension and effects on renin and intracellular endothelin-1. J Food Sci. (2020) 85:1328–37. doi: 10.1111/1750-3841.15115
73. Zhao YQ, Zhang L, Tao J, Chi CF, Wang B. Eight antihypertensive peptides from the protein hydrolysate of antarctic krill (Euphausia superba): isolation, identification, and activity evaluation on human umbilical vein endothelial cells (HUVECs). Food Res Int. (2019) 121:197–204. doi: 10.1016/j.foodres.2019.03.035
74. Bouchard J, Valookaran AF, Aloud BM, Raj P, Malunga LN, Thandapilly SJ. Impact of oats in the prevention/management of hypertension. Food Chem. (2022) 381:132198. doi: 10.1016/j.foodchem.2022.132198
75. Mao R, Wu L, Zhu N, Liu X, Liu R, Li Y. Naked oat (Avena nuda L.) oligopeptides: immunomodulatory effects on innate and adaptive immunity in mice via cytokine secretion, antibody production, and Th cells stimulation. Nutrients. (2019) 11:927. doi: 10.3390/nu11040927
76. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol. (1997) 15:297–322. doi: 10.1146/annurev.immunol.15.1.297
77. Tang Y, Li S, Yan J, Peng Y, Weng W, Yao X, et al. Bioactive components and health functions of oat bioactive components and health functions of oat. Food Rev Int. (2022) 133:1–20. doi: 10.1080/87559129.2022.2029477
78. Gao X, Zhang H, Zhuang W, Yuan G, Sun T, Jiang X. PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Sci Rep. (2014) 4:1–7. doi: 10.1038/srep05637
79. Lee CS, Choi EY, Lee SC, Koh HJ, Lee JH, Chung JH. Resveratrol inhibits hypoxia-induced vascular endothelial growth factor expression and pathological neovascularization. Yonsei Med J. (2015) 56:1678–85. doi: 10.3349/ymj.2015.56.6.1678
80. Wang J, Li LZ, Liu YG, Teng LR, Lu JH, Xie J. Investigations on the antifatigue and antihypoxic effects of Paecilomyces hepiali extract. Mol Med Rep. (2016) 13:1861–8. doi: 10.3892/mmr.2015.4734
81. Di Li, Ren J, Du Q, Liu P, Li Y. The anti-hypoxic effects of oat (Avena sativa L.) oligopeptides in mice. Am J Transl Res. (2021) 13:1657.
82. Kehrer JP, Lund LG. Cellular reducing equivalents and oxidative stress. Free Radic Biol Med. (1994) 17:65–75. doi: 10.1016/0891-5849(94)90008-6
83. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab. (1997) 17:1007–19. doi: 10.1097/00004647-199710000-00002
84. Halliwell B. Role of free radicals in the neurodegenerative diseases. Drugs Aging. (2001) 18:685–716. doi: 10.2165/00002512-200118090-00004
85. Rauchova H, Vokurkova M, Koudelova J. Hypoxia-induced lipid peroxidation in the brain during postnatal ontogenesis. Physiol Res. (2012) 61:S89. doi: 10.33549/physiolres.932374
86. Zhu N, Mao R, Liu R. Anti-fatigue effect of oat peptide in mice: an experimental study. Chinese J Public Health. (2018) 34:1242–5.
87. Surenkok O, Kin-Isler A, Aytar A, Gültekin Z. Effect of trunk-muscle fatigue and lactic acid accumulation on balance in healthy subjects. J Sport Rehabil. (2008) 17:380–6. doi: 10.1123/jsr.17.4.380
88. Xu C, Lv J, You S, Zhao Q, Chen X, Hu X. Supplementation with oat protein ameliorates exercise-induced fatigue in mice. Food Funct. (2013) 4:303–9. doi: 10.1039/c2fo30255a
89. Sahlin K, Sallstedt EK, Bishop D, Tonkonogi M. Turning down lipid oxidation during heavy exercise—what is the mechanism. J Physiol Pharmacol. (2008) 59:19–30.
90. Jia JM, Wu CF. Antifatigue activity of tissue culture extracts of Saussurea involucrata. Pharm Biol. (2008) 46:433–6.
91. You L, Zhao M, Regenstein JM, Ren J. In vitro antioxidant activity and in vivo anti-fatigue effect of loach (Misgurnus anguillicaudatus) peptides prepared by papain digestion. Food Chem. (2011) 124:188–94.
92. Ding JF, Li YY, Xu JJ, Su XR, Gao X, Yue FP. Study on effect of jellyfish collagen hydrolysate on anti-fatigue and anti-oxidation. Food Hydrocoll. (2011) 25:1350–3.
93. Zhang Y, Yao X, Bao B, Zhang Y. Anti-fatigue activity of a triterpenoid-rich extract from Chinese bamboo shavings (Caulis bamfusae in taeniam). Phyther Res. (2006) 20:872–6. doi: 10.1002/ptr.1965
94. Coombes JS, McNaughton LS. Effects of branched-chain amino acid supplementation on serum creatine kinase and lactate dehydrogenase after prolonged exercise. J Sports Med Phys Fitness. (2000) 40:240.
95. Xia Z, Cholewa JM, Dardevet D, Huang T, Zhao Y, Shang H. Effects of oat protein supplementation on skeletal muscle damage, inflammation and performance recovery following downhill running in untrained collegiate men. Food Funct. (2018) 9:4720–9. doi: 10.1039/c8fo00786a
96. Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the’magic bullet’. Nat Rev Drug Discov. (2003) 2:775–89. doi: 10.1038/nrd1198
97. Wang XH, Shao DH, Liang GW, Zhang R, Xin Q, Zhang T. Cyclooxygenase inhibitors in some dietary vegetables inhibit platelet aggregation function induced by arachidonic acid. J Exp Hematol. (2011) 19:1260–3.
98. Lee DH, Kim YJ, Kim HH, Cho HJ, Ryu JH, Rhee MH. Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets. Biomol Ther (Seoul). (2013) 21:54. doi: 10.4062/biomolther.2012.075
99. Oder E, Safo MK, Abdulmalik O, Kato GJ. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo? Br J Haematol. (2016) 175:24–30. doi: 10.1111/bjh.14264
100. Yu G, Wang F, Zhang B, Fan J. In vitro inhibition of platelet aggregation by peptides derived from oat (Avena sativa L.), highland barley (Hordeum vulgare Linn. var. nudum Hook. f.), and buckwheat (Fagopyrum esculentum Moench) proteins. Food Chem. (2016) 194:577–86. doi: 10.1016/j.foodchem.2015.08.058
101. Connolly ML, Tzounis X, Tuohy KM, Lovegrove JA. Hypocholesterolemic and prebiotic effects of a whole-grain oat-based granola breakfast cereal in a cardio-metabolic “at risk” population. Front Microbiol. (2016) 7:1675. doi: 10.3389/fmicb.2016.01675
102. Guo L, Tong LT, Liu L, Zhong K, Qiu J, Zhou S. The cholesterol-lowering effects of oat varieties based on their difference in the composition of proteins and lipids. Lipids Health Dis. (2014) 13:1–10. doi: 10.1186/1476-511X-13-182
103. Tong L, Guo L, Zhou X, Qiu J, Liu L, Zhong K, et al. Effects of dietary oat proteins on cholesterol metabolism of hypercholesterolaemic hamsters. J Sci Food Agric. (2016) 96:1396–401. doi: 10.1002/jsfa.7236
104. Daou C, Zhang H. Oat beta-glucan: its role in health promotion and prevention of diseases. Compr Rev Food Sci Food Saf. (2012) 11:355–65.
105. Maki KC, Shinnick F, Seeley MA, Veith PE, Quinn LC, Hallissey PJ. Food products containing free tall oil-based phytosterols and oat β-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr. (2003) 133:808–13. doi: 10.1093/jn/133.3.808
106. Anderson JW, Gilinsky NH, Deakins DA, Smith SF, O’Neal DS, Dillon DW, et al. Lipid responses of hypercholesterolemia men to oat-bran and wheat-bran intake. Am J Clin Nutr. (1991) 54:678–83. doi: 10.1093/ajcn/54.4.678
107. Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E. Oat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther. (2007) 14:203–12. doi: 10.1097/01.pap.0000249917.96509.e7
109. Hernández-Ledesma B, del Mar Contreras M, Recio I. Antihypertensive peptides: production, bioavailability and incorporation into foods. Adv Colloid Interface Sci. (2011) 165:23–35. doi: 10.1016/j.cis.2010.11.001
110. Singh BP, Vij S, Hati S. Functional significance of bioactive peptides derived from soybean. Peptides. (2014) 54:171–9. doi: 10.1016/j.peptides.2014.01.022
111. Inoue K, Gotou T, Kitajima H, Mizuno S, Nakazawa T, Yamamoto N. Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. J Biosci Bioeng. (2009) 108:111–5. doi: 10.1016/j.jbiosc.2009.03.007
112. Limón RI, Peñas E, Torino MI, Martínez-Villaluenga C, Dueñas M, Frias J. Fermentation enhances the content of bioactive compounds in kidney bean extracts. Food Chem. (2015) 172:343–52. doi: 10.1016/j.foodchem.2014.09.084
113. Nakahara T, Sano A, Yamaguchi H, Sugimoto K, Chikata H, Kinoshita E. Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances. J Agric Food Chem. (2010) 58:821–7. doi: 10.1021/jf903261h
114. Waseem M, Kumar S, Kumar A. Bioactive Peptides. Hauppauge, NY: Nova Science Publisher Inc. (2018).
115. Santos LF, Koblitz MGB. Proteases Bioquímica de Alimentos. Rio de Janeiro: Guanabara Koogan (2008). p. 78–103.
116. Madureira AR, Tavares T, Gomes AMP, Pintado ME, Malcata FX. Invited review : physiological properties of bioactive peptides obtained from whey proteins. J Dairy Sci. (2010) 93:437–55. doi: 10.3168/jds.2009-2566
117. Shi A, Liu H, Liu L, Hu H, Wang Q, Adhikari B. Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide. PLoS One. (2014) 9:e111188. doi: 10.1371/journal.pone.0111188
118. Zhang Q, Tong X, Li Y, Wang H, Wang Z, Qi B. Purification and characterization of antioxidant peptides from alcalase-hydrolyzed soybean (Glycine max L.) hydrolysate and their cytoprotective effects in human intestinal Caco-2 cells. J Agric Food Chem. (2019) 67:5772–81. doi: 10.1021/acs.jafc.9b01235
119. Zhu B, He H, Hou T. A comprehensive review of corn protein-derived bioactive peptides : production, characterization, bioactivities, and transport pathways. Compr Rev Food Sci Food Saf. (2019) 18:329–45. doi: 10.1111/1541-4337.12411
120. Zarei M, Ebrahimpour A, Abdul-Hamid A, Anwar F, Saari N. Production of defatted palm kernel cake protein hydrolysate as a valuable source of natural antioxidants. Int J Mol Sci. (2012) 13:8097–111. doi: 10.3390/ijms13078097
121. Cooper JB. Aspartic proteinases in disease: a structural perspective. Curr Drug Targets. (2002) 3:155–73. doi: 10.2174/1389450024605382
122. Mazorra-Manzano MA, Ramírez-Suarez JC, Yada RY. Plant proteases for bioactive peptides release: a review. Crit Rev Food Sci Nutr. (2018) 58:2147–63. doi: 10.1080/10408398.2017.1308312
123. Daroit DJ, Brandelli A. In vivo bioactivities of food protein-derived peptides–a current review. Curr Opin Food Sci. (2021) 39:120–9.
124. Kumar M, Tomar M, Potkule J, Verma R, Punia S, Mahapatra A. Advances in the plant protein extraction: mechanism and recommendations. Food Hydrocoll. (2021) 115:106595.
125. Zhu Z, Zhu W, Yi J, Liu N, Cao Y, Lu J, et al. Effects of sonication on the physicochemical and functional properties of walnut protein isolate. Food Res Int. (2018) 106:853–61. doi: 10.1016/j.foodres.2018.01.060
126. Jin J, Ma H, Wang B, Yagoub Ael-G, Wang K, He R. Effects and mechanism of dual-frequency power ultrasound on the molecular weight distribution of corn gluten meal hydrolysates. Ultrason Sonochem. (2016) 30:44–51. doi: 10.1016/j.ultsonch.2015.11.021
127. Malik MA, Sharma HK, Saini CS. High intensity ultrasound treatment of protein isolate extracted from dephenolized sunflower meal: effect on physicochemical and functional properties. Ultrason Sonochem. (2017) 39:511–9. doi: 10.1016/j.ultsonch.2017.05.026
128. Wali A, Ma H, Shahnawaz M, Hayat K, Xiaong J, Jing L. Impact of power ultrasound on antihypertensive activity, functional properties, and thermal stability of rapeseed protein hydrolysates. J Chem. (2017) 2017:1–11.
129. Wu Q, Zhang X, Jia J, Kuang C, Yang H. Effect of ultrasonic pretreatment on whey protein hydrolysis by alcalase: thermodynamic parameters, physicochemical properties and bioactivities. Process Biochem. (2018) 67:46–54.
130. Urbizo-Reyes U, San Martin-González MF, Garcia-Bravo J, López Malo Vigil A, Liceaga AM. Physicochemical characteristics of chia seed (Salvia hispanica) protein hydrolysates produced using ultrasonication followed by microwave-assisted hydrolysis. Food Hydrocoll. (2019) 97:105187.
131. Liang R, Cheng S, Wang X. Secondary structure changes induced by pulsed electric field affect antioxidant activity of pentapeptides from pine nut (Pinus koraiensis) protein. Food Chem. (2018) 254:170–84. doi: 10.1016/j.foodchem.2018.01.090
132. Wen C, Zhang J, Zhang H, Duan Y, Ma H. Plant protein-derived antioxidant peptides: isolation, identification, mechanism of action and application in food systems: a review. Trends Food Sci Technol. (2020) 105:308–22.
133. Everley RA, Croley TR. Ultra-performance liquid chromatography/mass spectrometry of intact proteins. J Chromatogr A. (2008) 1192:239–47. doi: 10.1016/j.chroma.2008.03.058
134. Pownall TL, Udenigwe CC, Aluko RE. Amino acid composition and antioxidant properties of pea seed (Pisum sativum L.) enzymatic protein hydrolysate fractions. J Agric Food Chem. (2010) 58:4712–8. doi: 10.1021/jf904456r
135. Yoshida T. Peptide separation by hydrophilic-interaction chromatography: a review. J Biochem Biophys Methods. (2004) 60:265–80. doi: 10.1016/j.jbbm.2004.01.006
136. Le Maux S, Nongonierma AB, FitzGerald RJ. Improved short peptide identification using HILIC–MS/MS: retention time prediction model based on the impact of amino acid position in the peptide sequence. Food Chem. (2015) 173:847–54. doi: 10.1016/j.foodchem.2014.10.104
137. Roblet C, Amiot J, Lavigne C, Marette A, Lessard M, Jean J. Screening of in vitro bioactivities of a soy protein hydrolysate separated by hollow fiber and spiral-wound ultrafiltration membranes. Food Res Int. (2012) 46:237–49.
138. Ketnawa S, Suwal S, Huang J, Liceaga AM. Original article Selective separation and characterisation of dual ACE and DPP-IV inhibitory peptides from rainbow trout (Oncorhynchus mykiss) protein hydrolysates. Int J Food Sci Technol. (2019) 54:1062–73.
139. Suwal S, Ketnawa S, Liceaga AM, Huang J. Electro-membrane fractionation of antioxidant peptides from protein hydrolysates of rainbow trout (Oncorhynchus mykiss) byproducts. Innov Food Sci Emerg Technol. (2018) 45:122–31.
140. Boja ES, Rodriguez H. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics. (2012) 12:1093–110. doi: 10.1002/pmic.201100387
Keywords: oat protein, bioactive peptides, antioxidant, antidiabetic, antihypertensive, immunomodulatory, antifatigue, antihypoxic
Citation: Rafique H, Dong R, Wang XL, Alim A, Aadil RM, Li L, Zou L and Hu XZ (2022) Dietary-Nutraceutical Properties of Oat Protein and Peptides. Front. Nutr. 9:950400. doi: 10.3389/fnut.2022.950400
Received: 22 May 2022; Accepted: 03 June 2022;
Published: 05 July 2022.
Edited by:
Monica Trif, Centre for Innovative Process Engineering, GermanyReviewed by:
Ahmed Mohamed, Benha University, EgyptJahan Zaib Ashraf, University of Foggia, Italy
Seydi Yıkmış, Namik Kemal University, Turkey
Copyright © 2022 Rafique, Dong, Wang, Alim, Aadil, Li, Zou and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinzhong Hu, eGluemhvbmdAMTI2LmNvbQ==